Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study. - Atas Ipek, Suheda; Yaslikaya, Sendag; Kara, Ismail Oguz; Koseci, Tolga; Bayram, Ertugrul; Asarkaya, Esra; Asoglu, Hatice; Turker, Mehmet; Aykut, Abdurrahman; Jeral Evinc, Seda; Alan, Ozkan; Yilmaz, Mehmet Emin; et al. (Journal of Clinical Medicine, 2026)